# Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer

> **NCT00872625** · PHASE1 · COMPLETED · sponsor: **Centre Antoine Lacassagne** · enrollment: 26 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** docetaxel
- **DRUG:** epirubicin hydrochloride
- **DRUG:** fluorouracil
- **PROCEDURE:** neoadjuvant therapy
- **PROCEDURE:** therapeutic conventional surgery
- **RADIATION:** hypofractionated radiation therapy
- **RADIATION:** image-guided radiation therapy
- **RADIATION:** radiation therapy
- **RADIATION:** stereotactic radiosurgery

## Key facts

- **NCT ID:** NCT00872625
- **Lead sponsor:** Centre Antoine Lacassagne
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-04
- **Final completion:** 2010-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00872625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00872625, "Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00872625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*